Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193805-20-001284
Filing Date
2020-10-16
Accepted
2020-10-16 12:22:16
Documents
2
Group Members
DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT HIF, L.P.DEERFIELD MGMT III, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.

Document Format Files

Seq Description Document Type Size
1 e620005_sc13d-oncorus.htm SC 13D 191908
2 e620005_ex99-1.htm EX-99.1 13442
  Complete submission text file 0001193805-20-001284.txt   206927
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13D

Mailing Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142 617-425-9200
Oncorus, Inc. (Subject) CIK: 0001671818 (see all company filings)

EIN.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91747 | Film No.: 201243411
SIC: 2834 Pharmaceutical Preparations